Melanoma

Melanoma Summary

Epidemiology:

Malignant melanoma is recognized as one of the most aggressive forms of skin cancer, with an estimated 99,780 new cases projected in the United States for 2022 ¹. It poses a significant challenge not only due to its rapid metastatic potential but also because it accounts for a large proportion of skin cancer deaths, making effective treatment a pressing concern ². Despite the concerning statistics associated with melanoma, spontaneous remission (SR) has been documented, albeit infrequently, in this malignancy ³. Reports indicate that complete spontaneous regression can occur in a range of 10-35% of cases characterized by primary melanoma; however, this phenomenon becomes exceedingly uncommon in metastatic scenarios ⁴.

Clinical Characteristics:

To date, there have been 30 reported cases of SR of either primary or metastatic melanoma. Several clinical trends can be observed among these cases. The patients’ ages at the time of remission ranged from 22 to 83 years, with a peak incidence between 50 and 70 years of age. Males exhibited slightly higher rates of SR than females (approximately 1.3:1). Most remissions occurred in cutaneous melanomas, although cases involving ocular (choroidal) and mucosal sites were also documented. See table 1 below for further information.

Histological Characteristics:

Patients who experienced SR of melanoma typically presented with advanced or metastatic disease, often involving cutaneous, ocular, or visceral sites such as the liver, lungs, and lymph nodes. The diagnosis was established through histopathological confirmation of malignant melanocytic cells in primary or metastatic lesions. In most cases, the primary sites were cutaneous regions of the extremities or trunk, with occasional involvement of the choroid, conjunctiva, and mucosal surfaces. Remission was characterized by partial or complete disappearance of measurable lesions, as verified by clinical examination, imaging, or histologic regression of tumor tissue. Several patients exhibited durable remission or prolonged disease stability without therapeutic intervention, far exceeding the expected prognosis for untreated malignant melanoma.

Proposed Contributing Mechanisms:

Various mechanisms have been proposed to explain SR in melanoma. The most frequently reported involve immune-mediated activation, often triggered by infection, surgical intervention, or tissue injury such as biopsy or trauma. Additional contributing factors included postoperative inflammation, autoimmune responses, and immune modulation following systemic stress or emotional events. In some instances, local factors such as tumor necrosis or ischemia were suggested to contribute to tumor regression. In contrast, others proposed an abscopal or immunologic “bystander” effect induced by immune recognition of melanoma antigens. These observations suggest that spontaneous remission in melanoma likely results from a combination of host immune reactivity and localized tumor-destructive processes rather than a single causative event.

Site and extent of regressions:

Most (28/30) SR events represented complete remissions, with only a few cases showing partial or site-specific tumor resolution. In several patients, remission occurred concurrently in primary and metastatic lesions, including cutaneous, lymphatic, and visceral sites such as the liver and lungs. Remission of metastatic deposits alone was documented in a subset of cases, most frequently involving lymph nodes or hepatic tissue. The duration of follow-up among reported cases ranged widely from a few weeks to over 16 years, with many patients maintaining long-term disease stability or survival exceeding typical prognostic expectations for metastatic melanoma.

Table 1: Melanoma SR Cases and Clinical Characteristics

References

1. Krebbers I., Kunst H., Baijens L., Hout M., & Waterval J. Spontaneous regression of a middle ear melanoma. Otology & Neurotology. 2021;42(10):e1572-e1576. doi:10.1097/mao.0000000000003371
2. Bordeanu-Diaconescu E., Cretu A., Grosu-Bularda A., et al. Comprehensive literature review on melanoma of unknown primary site triggered by an intriguing case report. Diagnostics. 2024;14(19):2210. doi:10.3390/diagnostics14192210
3. Paolino G , Rizzo N , Pampena R , et al. Spontaneous regression of primary melanoma and multiple melanocytic nevi in a patient with metastatic melanoma. Dermatol Pract Concept. 2020:e2020052. doi:10.5826/dpc.1003a52
4. Blanc F., Bertho N., Piton G., et al. Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHC cd163− macrophages. Cancer Immunol Immunother. 2023;72(11):3507-3521. doi:10.1007/s00262-023-03503-6
5. Daland EM, Holmes JA. Malignant melanomas; a clinical study. N Engl J Med. 1939;220:651–660.
6. Malleson N. Spontaneous regression of malignant melanoma. Br Med J. 1955;1:668.
7. Pelner L. Host-Tumor Antagonism XV; The Apparently Beneficial Effects of Acute Concurrent Infections or of Toxin Therapy on the Course of Malignant Melanoma. J Am Geriatr Soc. 1960;8:378–397.
8. Baker HW. Spontaneous regression of malignant melanoma. Am Surg. 1964;30:825–829.
9. Reese AB, Archila EA, Jones IS, Cooper WC. Necrosis of malignant melanoma of the choroid. Am J Ophthalmol. 1970;69:91-104.
10. Doyle JC, Bennett RC, Newing RK. Spontaneous regression of malignant melanoma. Med J Aust. 1973;2:551–552.
11. Scheffer CH, Binkhorst PG. Choroid melanoblastoma with signs of regression? Ophthalmologica. 1973;167:433.
12. Bulkley GB, Cohen MH, Banks PM, Char DH, Ketcham AS. Long-Term Spontaneous Regression of Malignant Melanoma with Visceral Metastases: Report of a Case with Immunologic Profile. Cancer. 1975;36:485–494.
13. Sindelar WF, Ketcham AS. Regression of Cancer Following Surgery. Natl Cancer Inst Monogr. 1976;44:81–84.
14. Bodurtha AJ, Berkelhammer J, Kim YH, Laucius JF, Mastrangelo MJ. A clinical, histologic and immunologic study of a case of metastatic malignant melanoma undergoing spontaneous remission. Cancer. 1976;37:735–742.
15. Nathanson L. Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms. Natl Cancer Inst Monogr. 1976;44:67–76.
16. McCarthy WH, Shaw HM, Milton GW. Spontaneous regression of metastatic malignant melanoma. Clin Oncol. 1978;4:203–207.
17. Mikhail GR, Gorsulowsky DC. Spontaneous regression of metastatic malignant melanoma. J Dermatol Surg Oncol. 1986;12:497–500.
18. Hogan DJ, Murphy F, Bremner RM. Spontaneous Resolution of a Giant Congenital Melanocytic Nevus. Pediatr Dermatol. 1988;5:170–172. doi:10.1111/j.1525-1470.1988.tb00932.x
19. Miller, C. V., Cook, I. S., Jayaramachandran, R., & Tyers, A. G.. Spontaneous regression of a conjunctival malignant melanoma. Orbit, 33, 139–141.
20. Bramhall, R. J., Mahady, K., & Peach, A. H.. Spontaneous regression of metastatic melanoma – Clinical evidence of the abscopal effect. European Journal of Surgical Oncology, 40, 34–41.
21. Ong SF, Harden M, Irandoust S, Lee RW. Spontaneous regression of pulmonary metastatic melanoma. Respirol Case Rep. 2015;4:7–9.
22. Yamada, S., Nawata, A., Yoshioka, M., Hiraki, T., Higashi, M., Hatanaka, K., & Tanimoto, A.. Complete regression of primary cutaneous malignant melanoma associated with distant lymph node metastasis: a teaching case mimicking blue nevus. BMC Research Notes, 9, 366.
23. Schlabe, J., Shah, K. A., Sheerin, F., Payne, M. J., & Fasanmade, A. A.. Complete spontaneous regression of a metastatic melanoma of the mandible: a case report and follow-up recommendations. International Journal of Oral and Maxillofacial Surgery, 47, 1519–1522.
24. Behnia, F., Zare, M., & Elojeimy, S.. Spontaneous regression of a metastatic melanoma pulmonary deposit following biopsy. Radiology Case Reports, 13, 580–582.
25. Schlabe J, Shah KA, Sheerin F, Payne MJ, Fasanmade AA. Complete spontaneous regression of a metastatic melanoma of the mandible: a case report and follow-up recommendations. Int J Oral Maxillofac Surg. 2018;47:1519–1522.
26. Koibuchi H, Ishikawa M, Yamamoto S, et al. Spontaneous regression of lymphovascular invasion and metastasis of malignant melanoma: ultrasound findings. J Ultrasound. 2023;26:905–907.
27. Bastian, B. C. (2003). Hypothesis: A role for telomere crisis in spontaneous regression of melanoma. Archives of Dermatology, 139(5), 667-668. doi:10.1001/archderm.139.5.667
28. Gaylord & Clowes, 1906. On Spontaneous Cure of Cancer. Surgery, Gynecology and Obstetrics 2: 1906; 633-658
29. Hula, M. 1976. Spontaneous Regression of the Primary Melanoblastoma. Plzensky Lekarsky Sbornik 31-34: 1976; 7-21
30. Rampen, F. H. 1979. Spontaneous Regression of Metastatic Malignant Melanoma. Clinical Oncology 5(1): Mar 1979; 91-92
31. Sroujieh, A. S. 1988. Spontaneous Regression of Intestinal Malignant Melanoma from an Occult Primary Site. Cancer 62(6): Sep 15 1988; 1247-1250
32. Vestnik Khirurgii Imeni I. I. Grekova 124(3): March 1980; 111-115